4.4 Review

Kidney transplantation: is it a solution to endothelial dysfunction?

Journal

INTERNATIONAL UROLOGY AND NEPHROLOGY
Volume 55, Issue 5, Pages 1183-1191

Publisher

SPRINGER
DOI: 10.1007/s11255-022-03415-x

Keywords

Kidney transplantation; Endothelial function; Inflammation; Mortality; Adiponectin

Ask authors/readers for more resources

Kidney transplantation significantly improves endothelial dysfunction in patients with end-stage renal disease, leading to a reduction in cardiovascular risk. However, further research is needed to understand the potential re-emergence of endothelial dysfunction in the long-term postoperative period.
Background Endothelial dysfunction is associated with elevated cardiovascular risk in patients with end-stage renal disease (ESRD). Kidney transplantation has demonstrated significant ability in reducing mortality and improving quality of life in recipients. Recent studies have also reported improvements in endothelial function following kidney transplantation; however, current literature is limited. Methods We performed a systematic review of PubMed/Medline, Web of Science, Scopus, Cochrane Library, and CINAHL databases for prospective cohort studies that assessed endothelial function prior to and following kidney transplantation via various clinical markers. Follow-up duration ranged from 1 month to 1 year. A meta-analysis of pooled data was conducted using random-effect models for four key markers: brachial artery flow-mediated dilatation (FMD), high-sensitivity C-reactive protein (hsCRP), nitroglycerin-mediated dilation (NMD), and adiponectin. Results We included nine studies in our final analysis with a total of 524 patients. Significant improvement of all four biomarkers was observed after transplantation. The mean difference was 2.81% (95% CI 1.92-3.71, p < 0.00001) for FMD, 17.27 mg/L (95% CI 5.82-28.72, p = 0.003) for hsCRP, 1.05%, (95% CI 0.56-1.54, p < 0.0001) for NMD, and 9.27 mu g/mL (95% CI 5.96-12.57, p < 0.00001) for adiponectin. Conclusion There is an immediate reversal of endothelial dysfunction in ESRD patients who undergo kidney transplantation, which may explain observed improvements in cardiovascular morbidity in transplant recipients. Future longitudinal studies are needed to understand possible re-emergence of endothelial dysfunction in the long-term postoperative period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available